Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer

By Igawa Satoshi   Ryuge Shinichiro   Fukui Tomoya   Otani Sakiko   Kimura Yuka   Katono Ken   Takakura Akira   Kubota Masaru   Mitsufuji Hisashi   Katagiri Masato   Yanase Nobuo   Masuda Noriyuki  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 447-452

Springer Publishing Company

Access to resources Recommend Favorite

Potential interactions between irinotecan and rifampin in a patient with small-cell lung cancer

By Yonemori Kan   Takeda Yuichiro   Toyota Emiko   Kobayashi Nobuyuki   Kudo Koichiro  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 206-209

Springer Publishing Company

Access to resources Recommend Favorite

Time Factor in Radiotherapy and Chemotherapy for Limited Disease Small-Cell Lung Cancer

By Nowara Elzbieta   Suwinski Rafal  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Chemoradiotherapy for Limited-disease Small-cell Lung Cancer in Elderly Patients Aged 75 Years or Older

By Shukuya Takehito   Takahashi Toshiaki   Harada Hideyuki   Ono Akira   Akamatsu Hiroaki   Taira Tetsuhiko   Kenmotsu Hirotsugu   Naito Tateaki   Murakami Haruyasu   Endo Masahiro   Takahashi Kazuhisa   Yamamoto Nobuyuki  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 176-183

Oxford University Press

Access to resources Recommend Favorite

A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer

By Fujiwara Keiichi   Ueoka Hiroshi   Kiura Katsuyuki   Tabata Masahiro   Takigawa Nagio   Hotta Katsuyuki   Umemura Shigeki   Sugimoto Keisuke   Shibayama Takuo   Kamei Haruhito   Harita Shingo   Okimoto Niro   Tanimoto Mitsune  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 755-760

Springer Publishing Company

Access to resources Recommend Favorite